Fidaxomicin: balancing evidence and economics
Am J Health Syst Pharm
.
2012 Jun 1;69(11):931.
doi: 10.2146/ajhp110539.
Authors
Vanessa Stevens
,
Nikolas Onufrak
,
Jack Brown
PMID:
22610024
DOI:
10.2146/ajhp110539
No abstract available
Publication types
Editorial
Comment
MeSH terms
Aminoglycosides / therapeutic use*
Anti-Bacterial Agents / therapeutic use*
Clostridium Infections / drug therapy*
Fidaxomicin
Humans
Substances
Aminoglycosides
Anti-Bacterial Agents
Fidaxomicin